R A Bertels1,2, L M Harteveld1,2, L H Filippini1,3, S A Clur1,4, N A Blom1,2,4. 1. The Center for Congenital Heart Disease Amsterdam-Leiden, Leiden, The Netherlands. 2. Department of Pediatric Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, The Netherlands. 3. Department of Pediatric Cardiology, Juliana Children's Hospital, The Hague, The Netherlands. 4. Department of Pediatric Cardiology, Academic Medical Center, Amsterdam, The Netherlands.
Abstract
AIMS: To assess the risk factors for left ventricular (LV) dysfunction in a paediatric population with idiopathic frequent premature ventricular contractions (PVCs) and asymptomatic ventricular tachycardias (VTs). METHODS AND RESULTS: Paediatric patients with the diagnosis of idiopathic frequent PVCs and asymptomatic VTs were retrospectively evaluated. Frequent PVCs were defined as ≥5% on 24 h Holter recording. Left ventricular dysfunction was defined as a shortening fraction of ≤28%. Seventy-two children were identified. Six patients showed LV dysfunction at diagnosis [age 10 ± 7 years, 2 (33%) had symptoms such as syncope, palpitations, fatigue, and dizziness], and 66 showed normal LV function [age 8 ± 6 years, 22 (33%) with symptoms]. Patients with LV dysfunction had a higher percentage of PVCs on Holter recordings (47 ± 16 vs. 16 ± 11%, P = 0.006), higher prevalence of VT [5 (83%) vs. 27 (41%), P = 0.045] and sustained ventricular tachycardia (sVT) [3 (50%) vs. 4 (6%), P = 0.001], and a higher number of couplets [6 (100%) vs. 34 (52%), P = 0.030]. In patients with LV dysfunction, two responded to medication (Classes Ic and II) and five underwent ablation, of which one was unsuccessful. During follow-up, LV function normalized in five of six patients. In patients with a normal function, none developed LV dysfunction during the follow-up. CONCLUSION: In children with idiopathic PVCs and asymptomatic VTs, development of LV dysfunction is associated with a higher burden of PVCs, the presence of sVTs, and couplets. Left ventricular dysfunction appears to be reversible if the burden of PVCs is decreased by medication or ablation. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: To assess the risk factors for left ventricular (LV) dysfunction in a paediatric population with idiopathic frequent premature ventricular contractions (PVCs) and asymptomatic ventricular tachycardias (VTs). METHODS AND RESULTS: Paediatric patients with the diagnosis of idiopathic frequent PVCs and asymptomatic VTs were retrospectively evaluated. Frequent PVCs were defined as ≥5% on 24 h Holter recording. Left ventricular dysfunction was defined as a shortening fraction of ≤28%. Seventy-two children were identified. Six patients showed LV dysfunction at diagnosis [age 10 ± 7 years, 2 (33%) had symptoms such as syncope, palpitations, fatigue, and dizziness], and 66 showed normal LV function [age 8 ± 6 years, 22 (33%) with symptoms]. Patients with LV dysfunction had a higher percentage of PVCs on Holter recordings (47 ± 16 vs. 16 ± 11%, P = 0.006), higher prevalence of VT [5 (83%) vs. 27 (41%), P = 0.045] and sustained ventricular tachycardia (sVT) [3 (50%) vs. 4 (6%), P = 0.001], and a higher number of couplets [6 (100%) vs. 34 (52%), P = 0.030]. In patients with LV dysfunction, two responded to medication (Classes Ic and II) and five underwent ablation, of which one was unsuccessful. During follow-up, LV function normalized in five of six patients. In patients with a normal function, none developed LV dysfunction during the follow-up. CONCLUSION: In children with idiopathic PVCs and asymptomatic VTs, development of LV dysfunction is associated with a higher burden of PVCs, the presence of sVTs, and couplets. Left ventricular dysfunction appears to be reversible if the burden of PVCs is decreased by medication or ablation. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Anna M E Noten; Nawin L Ramdat Misier; Janneke A E Kammeraad; Sip Wijchers; Ingrid M Van Beynum; Michiel Dalinghaus; Thomas B Krasemann; Sing-Chien Yap; Natasja M S de Groot; Tamas Szili-Torok Journal: Pediatr Cardiol Date: 2022-04-29 Impact factor: 1.838
Authors: Areej Alotaibi; Ghadir A Alakhfash; Ali Alakhfash; Tayseer Mahmoud; Alhasan A Alakhfash; Abdullah Al Qwaee; Abdulrahman Mesned Journal: Cureus Date: 2022-06-05
Authors: Robin A Bertels; Janneke A E Kammeraad; Anna M Zeelenberg; Luc H Filippini; Ingmar Knobbe; Irene M Kuipers; Nico A Blom Journal: Pediatr Cardiol Date: 2021-01-30 Impact factor: 1.655